Business Description
BioForce Nanosciences Holdings Inc
NAICS : 311999
SIC : 2099
ISIN : US09064C1071
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -1089 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 88.2 | |||||
3-Year EPS without NRI Growth Rate | 87.3 | |||||
3-Year FCF Growth Rate | 26.3 | |||||
3-Year Book Growth Rate | -72.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.03 | |||||
9-Day RSI | 58.79 | |||||
14-Day RSI | 54.14 | |||||
6-1 Month Momentum % | -11.82 | |||||
12-1 Month Momentum % | -52.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -40083.33 | |||||
ROIC % | -28.25 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -66.33 | |||||
EV-to-EBITDA | -66.33 | |||||
EV-to-FCF | -601.98 | |||||
Earnings Yield (Greenblatt) % | -1.51 | |||||
FCF Yield % | -0.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BFNH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BioForce Nanosciences Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.022 | ||
Beta | -0.36 | ||
Volatility % | 111.89 | ||
14-Day RSI | 54.14 | ||
14-Day ATR ($) | 0.07522 | ||
20-Day SMA ($) | 1.057 | ||
12-1 Month Momentum % | -52.68 | ||
52-Week Range ($) | 0.1631 - 2.113 | ||
Shares Outstanding (Mil) | 29.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BioForce Nanosciences Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BioForce Nanosciences Holdings Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
BioForce Nanosciences Holdings Inc Frequently Asked Questions
What is BioForce Nanosciences Holdings Inc(BFNH)'s stock price today?
When is next earnings date of BioForce Nanosciences Holdings Inc(BFNH)?
Does BioForce Nanosciences Holdings Inc(BFNH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |